United States· US:43063-548_2f3a8f82-8530-3a64-e063-6294a90aa0b0
Lovastatin
A lovastatin product containing lovastatin, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lovastatin is registered in 10 of 19 countries.
Countries holding a registration under ATC C10AA02 (lovastatin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Lovastatin · ATC C10AA02
10 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lovastatin costs, country by country.
Normalised to the WHO defined daily dose (45 mg), the median price runs from $0.20 in Spain to $0.55 in Italy — a ×2.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lovastatin · price per daily dose (45 mg)
USD · FX 28 Sept 2026
- IT Italy$0.55
- ES Spain$0.20
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LOVASTATIN
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- C10AA02
- ATC class
- Lovastatin
- Defined daily dose
- 45 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 10
- ndc1143063-548-14
- ndc1143063-548-30
- ndc1143063-548-90
- ndc11430635481414 TABLET in 1 BOTTLE, PLASTIC (43063-548-14)
- ndc11430635483030 TABLET in 1 BOTTLE, PLASTIC (43063-548-30)
- ndc11430635489090 TABLET in 1 BOTTLE, PLASTIC (43063-548-90)
- ndc114306354893180 TABLET in 1 BOTTLE, PLASTIC (43063-548-93)
- ndc1143063548951000 TABLET in 1 BOTTLE, PLASTIC (43063-548-95)
- ndc1143063-548-93
- ndc1143063-548-95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
338 interactions on record for lovastatin.
Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lovastatin · interactions on record
338 records
- 17 severe
- 176 moderate
- 4 minor
- 140 info
Most severe, free to view
- KetoconazoleH02CA03severe
- ErythromycinJ01FA01severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lovastatin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLovacardHexal A/S
- SpainCOLESVIR 40 mg COMPRIMIDOSIndustria Quimica Y Farmaceutica Vir S.A.
- ItalyLOVASTATINA DOCDOC GENERICI S.R.L.
- CzechiaMEDOSTATINMedochemie Ltd., Limassol
- United KingdomMevacor 40mg tabletsImported (United States)
- CanadaLOVASTATINAA PHARMA INC
- NorwayLovabetaBetapharm
- PolandLiproxBiofarm Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Cyprus · Lovarem, Lovasynt
- Czechia · Medostatin
- Germany · Lovabeta
- Denmark · Lovacodan
- Spain · Colesvir, Lovastatina Cinfa
- Greece · Lovatex, Velkalov
- Italy · Lovastatina Doc, Lovastatina Eg
- Malta · Medostatin
- Poland · Liprox, Lovasterol
- Portugal · Lipdaune, Lipus
- Romania · Lovastatină Arena
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/854af0ba-e0e6-4c50-9346-a3206db77fd9 GET /v1/drugs/854af0ba-e0e6-4c50-9346-a3206db77fd9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "40",
"substance": "LOVASTATIN",
"productndc": "43063-548",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA075991",
"marketing_category": "ANDA"
}See everything about lovastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.